We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Detecto

Download Mobile App





Abbott Launches Molecular Test for Novel Coronavirus (COVID-19)

By HospiMedica International staff writers
Posted on 27 Mar 2020
Print article
Illustration
Illustration
Abbott (Lake Forest, IL, USA) has received emergency use authorization (EUA) from the FDA for its molecular test for the identification of SARS-CoV-2, the virus that causes COVID-19. The Abbott RealTime SARS-CoV-2 EUA test can be used on Abbott's molecular instrument, the m2000 RealTime system, by authorized laboratories in the US. These lab instruments, which test for a broad array of infectious diseases and are found in health systems across the US, can now have access to a SARS-CoV-2 assay to help healthcare providers deal with the high demand for testing. Abbott will be working with health systems and government authorities to deploy additional m2000 systems where they are needed.

The company is deploying 150,000 laboratory tests immediately. Tests already have been sent to hospital and academic medical center labs in 18 states including Illinois, California, New York, Massachusetts and Washington. Abbott is scaling up production at its US manufacturing location to reach capacity for one million tests per week by end of March.

"Our scientists, many of whom worked on Abbott's first HIV test and the Zika tests, worked around the clock to develop these molecular tests," said Daman Kowalski, vice president and head of, Molecular Diagnostics, Abbott. "Providing people at the frontlines of this pandemic with critical tests will help ensure proper care for patients and help protect our communities."

"Diagnostic testing is at the heart of the solution for any infectious disease outbreak because it can help prevent the spread of a virus," said Christian Bréchot, MD, Ph.D., president of the Global Virus Network and a professor at the University of South Florida. "In the case of novel coronavirus, having technology that can be deployed to the frontline will make a real difference in the effort to stop the spread of this virus — something we are all working together to achieve."

Related Links:
Abbott

BMP Whole Blood Analyzer: GEM Premier ChemSTAT
Gold Supplier
COVID-19 Antigen Self-Test
Panbio COVID-19 Antigen Self-Test
New
Urine Test Strip
HealthMate DA-7
New
Fecal Occult Blood Test
iFOB Assay

Print article
Radcal

Channels

AI

view channel
Image: AI transforms smartwatch ECG signals into a diagnostic tool for heart failure (Photo courtesy of Pexels)

AI-Based Smartwatch Accurately Detects Heart Failure Using ECG Signals

People with a weak heart pump might not have symptoms, but this common form of heart disease affects about 2% of the population and 9% of people over 60. When the heart cannot pump enough oxygen-rich blood,... Read more

Critical Care

view channel
Image: Quantra Hemostasis Analyzer (Photo courtesy of HemoSonics)

Next-Gen POC Whole Blood Hemostasis System Recognizes Specific Needs of EDs and ORs

Current hemostatic tests provide only a subset of needed information, or take too long to be useful in critical bleeding situations, forcing clinicians to use iterative transfusion protocols that do not... Read more

Surgical Techniques

view channel
Image: CystoSmart image enhancement and AI diagnostic tool will enhance cancer detection (Photo courtesy of Claritas HealthTech)

AI Diagnostic Tool Improves Cancer Detection in Cystoscope Images of Bladder

Bladder cancer is the 10th commonest cancer worldwide and the 6th commonest cancer amongst men. It is known to have high recurrence rates and significant risks of disease progression. Early detection of... Read more

Patient Care

view channel
Image: Automated cleaning system allows endoscopes to be cleaned direct from clinic (Photo courtesy of Aston University)

World’s First Automated Endoscope Cleaner Fights Antimicrobial Resistance

Endoscopes are long, thin tubes with a light and camera at one end. Due to the sensitivity of the materials and electronics they cannot be sterilized in an autoclave (a machine that uses steam under pressure),... Read more

Health IT

view channel
Image: Using digital data can improve health outcomes (Photo courtesy of Unsplash)

Electronic Health Records May Be Key to Improving Patient Care, Study Finds

When a patient gets transferred from a hospital to a nearby specialist or rehabilitation facility, it is often difficult for personnel at the new facility to access the patient’s electronic health records... Read more

Business

view channel
Image: The global multiparameter patient monitoring systems market is expected to surpass USD 15 billion by 2028 (Photo courtesy of Unsplash)

Global Multiparameter Patient Monitoring Systems Market Driven by Rising Chronic Illnesses

Multi-parameter patient monitoring equipment is used to assess the vital signs of patients who are suffering from a serious illness. These devices are meant to give the number of data sets on one screen... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.